NexMed is an innovative
drug developer that is leveraging its
proprietary drug delivery technology
to develop a significant pipeline of
innovative pharmaceutical products to
address a host of medical needs. The
company offers large pharmaceutical
companies the opportunity to incorporate
NexACT® into their existing drugs,
allowing these companies to develop
new patient-friendly transdermal products
and to extend patent lifespans and brand
equity.
